{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:09:35Z","timestamp":1763550575290,"version":"3.45.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,19]]},"DOI":"10.7759\/cureus.97217","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:06:29Z","timestamp":1763550389000},"source":"Crossref","is-referenced-by-count":0,"title":["Bone Marrow CD8+ Cytotoxic T-lymphocyte Subset: A Prognostic Indicator in Acute Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Randa  A","family":"Osman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah  M","family":"Almuslimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Z","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Hanafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Samra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza M","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01600-3","article-title":"Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status","volume":"15","author":"Jiao X","year":"2025","unstructured":"Jiao X, Zhou J, Liang X, et al.. Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status. Sci Rep. 2025, 15:17128. 10.1038\/s41598-025-01600-3","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-020-01892-4","article-title":"miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling","volume":"394","author":"Sha C","year":"2021","unstructured":"Sha C, Jia G, Jingjing Z, Yapeng H, Zhi L, Guanghui X. miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling. Naunyn Schmiedebergs Arch Pharmacol. 2021, 394:177-87. 10.1007\/s00210-020-01892-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner H","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, et al.. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022, 140:1345-77. 10.1182\/blood.2022016867","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-696070","article-title":"The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications","volume":"129","author":"Medyouf H","year":"2017","unstructured":"Medyouf H. The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications. Blood. 2017, 129:1617-26. 10.1182\/blood-2016-11-696070","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5045\/br.2018.53.3.198","article-title":"The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia","volume":"53","author":"Park Y","year":"2018","unstructured":"Park Y, Lim J, Kim S, Song I, Kwon K, Koo S, Kim J. The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia. Blood Res. 2018, 53:198-204. 10.5045\/br.2018.53.3.198","journal-title":"Blood Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-023-00536-9","article-title":"Effect of changes in lymphocyte subsets at diagnosis in acute myeloid leukemia on prognosis: association with complete remission rates and relapse free survivals","volume":"16","author":"Park SH","year":"2023","unstructured":"Park SH, Bae MH, Park CJ, Cho YU, Jang S, Lee JH, Lee KH. Effect of changes in lymphocyte subsets at diagnosis in acute myeloid leukemia on prognosis: association with complete remission rates and relapse free survivals. J Hematop. 2023, 16:73-84. 10.1007\/s12308-023-00536-9","journal-title":"J Hematop"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171460798","article-title":"The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells","volume":"98","author":"Hansen MH","year":"2001","unstructured":"Hansen MH, Nielsen H, Ditzel HJ. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc Natl Acad Sci U S A. 2001, 98:12659-64. 10.1073\/pnas.171460798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg SA","year":"2015","unstructured":"Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015, 348:62-8. 10.1126\/science.aaa4967","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21349","article-title":"Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes","volume":"90","author":"Aggarwal N","year":"2016","unstructured":"Aggarwal N, Swerdlow SH, TenEyck SP, Boyiadzis M, Felgar RE. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes. Cytometry B Clin Cytom. 2016, 90:349-57. 10.1002\/cyto.b.21349","journal-title":"Cytometry B Clin Cytom"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1418792","article-title":"The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis","volume":"15","author":"Sun K","year":"2024","unstructured":"Sun K, Shi ZY, Wang YZ, et al.. The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis. Front Immunol. 2024, 15:1418792. 10.3389\/fimmu.2024.1418792","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.9734\/JAMMR\/2018\/46278","article-title":"Bone marrow lymphocyte subsets in newly diagnosed acute myeloid leukemia patients and their relation to standard prognostic factors and response to induction therapy","volume":"28","author":"El Gendi HM","year":"2019","unstructured":"El Gendi HM, Mostafa NBH, William Labib MM. Bone marrow lymphocyte subsets in newly diagnosed acute myeloid leukemia patients and their relation to standard prognostic factors and response to induction therapy. J Adv Med Med Res. 2019, 28:1-8. 10.9734\/JAMMR\/2018\/46278","journal-title":"J Adv Med Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2153-5","article-title":"Bone marrow T-cell percentage: a novel prognostic indicator in acute myeloid leukemia","volume":"105","author":"Ismail MM","year":"2017","unstructured":"Ismail MM, Abdulateef NA. Bone marrow T-cell percentage: a novel prognostic indicator in acute myeloid leukemia. Int J Hematol. 2017, 105:453-64. 10.1007\/s12185-016-2153-5","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12594","article-title":"The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia","volume":"39","author":"Alcasid M","year":"2017","unstructured":"Alcasid M, Ma L, Gotlib JR, Arber DA, Ohgami RS. The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia. Int J Lab Hematol. 2017, 39:129-36. 10.1111\/ijlh.12594","journal-title":"Int J Lab Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1733304","article-title":"Study of bone marrow lymphocyte subset in acute myeloid leukemia","volume":"14","author":"Dange P","year":"2022","unstructured":"Dange P, Tyagi S, Juneja R, Seth T, Saxena R. Study of bone marrow lymphocyte subset in acute myeloid leukemia. J Lab Physicians. 2022, 14:151-6. 10.1055\/s-0041-1733304","journal-title":"J Lab Physicians"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-012-1251-x","article-title":"Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia","volume":"138","author":"Najera Chuc AE","year":"2012","unstructured":"Najera Chuc AE, Cervantes LA, Retiguin FP, Ojeda JV, Maldonado ER. Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia. J Cancer Res Clin Oncol. 2012, 138:1427-32. 10.1007\/s00432-012-1251-x","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400255-bone-marrow-cd8-cytotoxic-t-lymphocyte-subset-a-prognostic-indicator-in-acute-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:06:30Z","timestamp":1763550390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400255-bone-marrow-cd8-cytotoxic-t-lymphocyte-subset-a-prognostic-indicator-in-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.97217","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}